Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Lupin: United States Food and Drug Administration (US FDA) has approved its ranibizumab, RanluspecTM (ranibizumab-hkdz), as an interchangeable biosimilar referencing Lucentis® (Genentech).
5 Jun 2026, 9:59AMCapacite Infraprojects in focus on bagging Rs 589cr order from Raymond Realty arm.
4 Jun 2026, 11:35AML&T wins order for Power Transmission & Distribution Business in Saudi Arabia
29-10-2025 10:13:15The ePlane Company signs MOU with Ramco Systems
27-10-2025 12:42:39Refex Industries gets an order worth Rs. 300 Cr from a mining entity in Jharkhand
24-10-2025 13:57:18Diwali Stocks Picks 2025
